Clinical Trial Update: QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy

View source ↗

Summary

An ongoing QUANTACT clinical trial evaluating pangenomic quantitative alterations in cancer therapy is currently enrolling by invitation for patients with solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Solid Tumor | Status: ENROLLING_BY_INVITATION